Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,099,378 papers from all fields of science
Search
Sign In
Create Free Account
solufenum
Known as:
lysine-p-isobutylphenylpropionate
, Ibuprofen Lysine
, L-lysine, mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate)
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
26 relations
Ankylosing spondylitis
Asthma
Bronchial Hyperreactivity
Bursitis
Expand
Broader (2)
Ibuprofen
Lysine
Narrower (2)
Neoprofen
Saren
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Dissolution rates of over-the-counter painkillers: a comparison among formulations.
M. Alemanni
,
Sergio C. Gatoulis
,
M. Voelker
Minerva Medica
2016
Corpus ID: 21442297
BACKGROUND We wanted to compare the dissolution profile of several over-the-counter analgesics to understand whether the…
Expand
2012
2012
Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.
Karen E. Corff
,
K. Sekar
The Journal of Pediatric Pharmacology and…
2012
Corpus ID: 20671469
When medical management is warranted for closure of a persistent patent ductus arteriosus (PDA) in premature infants, treatment…
Expand
2008
2008
Repeated bowel perforations with Ibuprofen lysine: a case report.
G. Peitz
,
E. Hoie
,
S. Hoy
,
A. Anderson-Berry
The Journal of Pediatric Pharmacology and…
2008
Corpus ID: 19194962
Non-steroidal anti-inflammatory drugs (NSAID) have been used to close the patent ductus arteriosus in neonates for over two…
Expand
2007
2007
Pharmacologic, pharmacodynamic, and pharmacokinetic considerations with intravenous Ibuprofen lysine.
E. Capparelli
The Journal of Pediatric Pharmacology and…
2007
Corpus ID: 24542294
Patent ductus arteriosus (PDA) is a common complication in preterm infants. An intravenous (IV) cyclooxygenase (COX) inhibitor is…
Expand
Review
2005
Review
2005
Pharmacology Review: Intravenous Ibuprofen for Preterm Newborns
J. Aranda
,
Ronald L. Thomas
2005
Corpus ID: 73221615
Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), is a chiral compound derived from arylproprionic acid. It is used…
Expand
2003
2003
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin.
P. Santi
,
S. Nicoli
,
+6 authors
P. Colombo
International journal of pharmaceutics
2003
Corpus ID: 7526764
1998
1998
Transformation of a liposomal dispersion containing ibuprofen lysinate and phospholipids into mixed micelles - physico-chemical characterization and influence on drug permeation through excised human…
I. Stoye
,
K. Schröder
,
C. Müller-Goymann
European journal of pharmaceutics and…
1998
Corpus ID: 25164444
1994
1994
Comparison of single-dose ibuprofen lysine, acetylsalicylic acid, and placebo for moderate-to-severe postoperative dental pain.
Nelson Sl
,
Brahim Js
,
Kornhauser Sh
,
Greene Ss
,
Su Lj
1994
Corpus ID: 57463943
Abstract In a single-dose, double-blind, parallel-group, single-site study, ibuprofen lysine 200 mg (IBL 200) was compared with…
Expand
1994
1994
Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
P. Müller
,
B. Simon
Arzneimittel-Forschung
1994
Corpus ID: 34165646
Acetylsalicylic acid (ASA, CAS 50-78-2) and ibuprofen (IB) are commonly used over-the-counter drugs for short-term treatment of…
Expand
1977
1977
Bioavailability and platelet aggregation inhibitory activity of solufenum. A comparison with ibuprofen.
R. Latini
,
S. Villa
,
M. Gerna
,
G. Tognoni
,
G. de Gaetano
International journal of clinical pharmacology…
1977
Corpus ID: 32573408
Bioavailability and platelet aggregation inhibitory activity of the lysine salt of ibuprofen (solufenum) were compared with those…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE